Glycation in Parkinson's disease and Alzheimer's disease-Reference-Cited by-同舟云学术

Glycation in Parkinson's disease and Alzheimer's disease

Published:2016-03-04 Issue:6 Volume:31 Page:782-790
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Vicente Miranda Hugo¹,El-Agnaf Omar M. A.²,Outeiro Tiago Fleming¹³⁴

Affiliation:

1. CEDOC - Chronic Diseases Research Center; NOVA Medical School; Lisboa Portugal

2. Neurological Disorders Center; Qatar Biomedical Research Institute, and College of Science and Engineering, Hamad Bin Khalifa University (HBKU); Education City Qatar Foundation, P.O. Box 5825 Doha Qatar

3. Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); University Medical Center Goettingen; Goettingen Germany

4. Max Planck Institute for Experimental Medicine; Goettingen Germany

Funder

Fundação para a Ciência e Tecnologia (FCT), Portugal

the DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference140 articles.

1. Biochemistry and molecular cell biology of diabetic complications;Brownlee;Nature,2001

2. Diabetes and advanced glycation endproducts;Vlassara;J Intern Med,2002

3. Action des acides amines sur les sucre: formation des melanoidines par voie methodique;Maillard;C R Hebd Seances Acad Sci,1912